More on the pathogenesis of thrombotic thrombocytopenic purpura. Comment on "Acquired thrombotic thrombocytopenic purpura without detectable anti-ADAMTS13 antibodies: a possible underlying autoimmune mechanism" and on "The different faces of thrombotic thrombocytopenic purpura".
作者信息
Peyvandi Flora
机构信息
Università degli Studi di Milano, Department of Pathophysiology and Transplantation, Milan, Italy; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan.
出版信息
Haematologica. 2025 Jun 1;110(6):1443-1444. doi: 10.3324/haematol.2024.287163. Epub 2025 Jan 30.
Abstract
摘要
相似文献
1
More on the pathogenesis of thrombotic thrombocytopenic purpura. Comment on "Acquired thrombotic thrombocytopenic purpura without detectable anti-ADAMTS13 antibodies: a possible underlying autoimmune mechanism" and on "The different faces of thrombotic thrombocytopenic purpura".
Haematologica. 2025 Jun 1;110(6):1443-1444. doi: 10.3324/haematol.2024.287163. Epub 2025 Jan 30.
2
The third form of thrombotic thrombocytopenic purpura shows up again: what is it, does it even exist, how to find out? Comment on "Acquired thrombotic thrombocytopenic purpura without detectable anti-ADAMTS13 antibodies: a possible underlying autoimmune mechanism" and on "The different faces of thrombotic thrombocytopenic purpura".
Haematologica. 2025 Jun 1;110(6):1445-1448. doi: 10.3324/haematol.2025.287535. Epub 2025 Feb 27.
3
Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy.
Lancet Haematol. 2016 Nov;3(11):e537-e546. doi: 10.1016/S2352-3026(16)30125-9. Epub 2016 Oct 3.
4
ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.
Haematologica. 2008 Feb;93(2):232-9. doi: 10.3324/haematol.11739. Epub 2008 Jan 26.
5
Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy.
Lancet Haematol. 2016 May;3(5):e237-45. doi: 10.1016/S2352-3026(16)30018-7. Epub 2016 Apr 16.
6
Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura.
Haematologica. 2010 Sep;95(9):1555-62. doi: 10.3324/haematol.2009.019299. Epub 2010 Apr 7.
7
Acquired Thrombotic Thrombocytopenic Purpura Without Anti-ADAMTS13 Antibody Caused by Influenza A (H1N1) Virus Successfully Treated by Plasma Exchange: A Case Report.
Am J Case Rep. 2021 Aug 2;22:e932251. doi: 10.12659/AJCR.932251.
8
Human neutrophil peptides and complement factor Bb in pathogenesis of acquired thrombotic thrombocytopenic purpura.
Haematologica. 2016 Nov;101(11):1319-1326. doi: 10.3324/haematol.2016.149021. Epub 2016 Aug 4.
9
Acquired thrombotic thrombocytopenic purpura without detectable anti-ADAMTS13 antibodies: a possible underlying autoimmune mechanism.
Haematologica. 2025 Jun 1;110(6):1368-1372. doi: 10.3324/haematol.2024.285391. Epub 2024 Sep 26.
10
A case of severe ADAMTS13 deficiency presenting as thrombotic thrombocytopenic purpura in pregnancy.
Med Pregl. 2012 Sep-Oct;65(9-10):436-9. doi: 10.2298/mpns1210436n.
本文引用的文献
1
The different faces of thrombotic thrombocytopenic purpura.
Haematologica. 2025 Jun 1;110(6):1245-1247. doi: 10.3324/haematol.2024.286504. Epub 2024 Nov 14.
2
Acquired thrombotic thrombocytopenic purpura without detectable anti-ADAMTS13 antibodies: a possible underlying autoimmune mechanism.
Haematologica. 2025 Jun 1;110(6):1368-1372. doi: 10.3324/haematol.2024.285391. Epub 2024 Sep 26.
3
Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients.
Haematologica. 2023 Nov 1;108(11):3152-3155. doi: 10.3324/haematol.2022.282478.
4
Thrombotic Thrombocytopenic Purpura: From 1972 to 2022 and Beyond.
Semin Thromb Hemost. 2022 Nov;48(8):926-936. doi: 10.1055/s-0042-1749589. Epub 2022 Jul 6.
5
Acquired Thrombotic Thrombocytopenic Purpura Without Anti-ADAMTS13 Antibody Caused by Influenza A (H1N1) Virus Successfully Treated by Plasma Exchange: A Case Report.
Am J Case Rep. 2021 Aug 2;22:e932251. doi: 10.12659/AJCR.932251.
6
The ADAMTS13-von Willebrand factor axis in COVID-19 patients.
J Thromb Haemost. 2021 Feb;19(2):513-521. doi: 10.1111/jth.15191. Epub 2020 Dec 18.
7
ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura.
J Thromb Haemost. 2020 Oct;18(10):2486-2495. doi: 10.1111/jth.15006. Epub 2020 Sep 11.
8
Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura.
Blood. 2020 Jul 16;136(3):353-361. doi: 10.1182/blood.2019004221.
9
ADAMTS13-specific circulating immune complexes as potential predictors of relapse in patients with acquired thrombotic thrombocytopenic purpura.
Eur J Intern Med. 2017 Apr;39:79-83. doi: 10.1016/j.ejim.2016.11.003. Epub 2016 Nov 22.
10
Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies.
J Thromb Haemost. 2017 Feb;15(2):312-322. doi: 10.1111/jth.13571. Epub 2017 Jan 30.
Zotero 插件